22.418 articles found

Prevention and treatment of synucleinopathic and amyloidogenic disease

DORA SCHENK DALE B MASLIAH ELI.

· 2005-08-09

MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact.

Lau YS, Novikova L, Roels C.

Neurosci Res · 2005-08-01

DOI: 10.1016/j.neures.2005.04.010PMID: 15936837

Stem cell treatment for Parkinson's disease: an update for 2005.

Snyder BJ, Olanow CW.

Curr Opin Neurol · 2005-08-01

DOI: 10.1097/01.wco.0000174298.27765.91PMID: 16003112

A pilot study of therapeutic massage for people with Parkinson's disease: the added value of user involvement.

Paterson C, Allen JA, Browning M, Barlow G, Ewings P.

Complement Ther Clin Pract · 2005-08-01

DOI: 10.1016/j.ctcp.2004.12.008PMID: 16005833

Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease.

Chen JJ, Swope DM.

J Clin Pharmacol · 2005-08-01

DOI: 10.1177/0091270005277935PMID: 16027398

Treatment of depression in the medically ill.

Krishnan KR.

J Clin Psychopharmacol · 2005-08-01

DOI: 10.1097/01.jcp.0000162808.92194.2aPMID: 16027555

Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.

Lazzarini M, Salum C, Del Bel EA, Del Bel EA.

Psychopharmacology (Berl) · 2005-08-01

DOI: 10.1007/s00213-005-2222-6PMID: 15806417

Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.

Izzo E, Sanna PP, Koob GF.

Pharmacol Biochem Behav · 2005-08-01

DOI: 10.1016/j.pbb.2005.04.017PMID: 16005056

Pallidal stimulation reduces treatment-induced dyskinesias in "minimal-change" multiple system atrophy.

Huang Y, Garrick R, Cook R, O'Sullivan D, Morris J, Halliday GM.

Mov Disord · 2005-08-01

DOI: 10.1002/mds.20497PMID: 15852363

Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy.

Teixeira AL, Maia DP, Cardoso F.

Parkinsonism Relat Disord · 2005-08-01

DOI: 10.1016/j.parkreldis.2005.02.007PMID: 15878690

The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease.

Tousi B, Subramanian T.

Parkinsonism Relat Disord · 2005-08-01

DOI: 10.1016/j.parkreldis.2004.11.003PMID: 15949966

The feasibility of using cognitive behaviour therapy for depression associated with Parkinson's disease: a literature review.

Cole K, Vaughan FL.

Parkinsonism Relat Disord · 2005-08-01

DOI: 10.1016/j.parkreldis.2005.03.002PMID: 15970452